agios savvas taxi LLC

3321 21st street
astoria, new york 11106

NYS Entity Status
ACTIVE

NYS Filing Date
DECEMBER 03, 2013

NYS DOS ID#
4495371

County
QUEENS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - AGIOS SAVVAS TAXI LLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • A New Kind of Classroom: No Grades, No Failing, No Hurry
    By KYLE SPENCER - Friday Aug 11, 2017

    Mastery-based learning allows students to learn at their own pace.

    Source: NYT > Home Page
  • For 18 Hours, Cabbie Sat Dead in Front Seat
    By KIM BARKER - Monday Aug 14, 2017

    A driver parked his taxi to take a break in SoHo. He died behind the wheel. Then, for nearly a day, New Yorkers went about their lives — just feet from his body.

    Source: NYT > Home Page
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • New York Today: New York Today: An Excursion to Astoria
    By JONATHAN WOLFE - Monday Sep 18, 2017

    Monday: What to see, eat and do in Astoria, a food truck from Macao, and a free Citi Bike ride.

    Source: NYT > Home Page
  • With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug
    By Ben Fidler - Tuesday Aug 1, 2017

    [Updated, 2:10 pm ET, see below] The FDA approved a new blood cancer drug today. Called enasidenib (Idhifa), it’s the latest therapy sold by Celgene, the big cancer drugmaker from Summit, NJ. But the news is significant for other reasons. The drug is the first product to come from the labs of Agios Pharmaceuticals (NASDAQ: […]

    Source: Xconomy New York